Selected article for: "immune response and risk factor"

Author: Signorini, Cinzia; Pignatti, Patrizia; Coccini, Teresa
Title: How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn
  • Cord-id: ymygywzo
  • Document date: 2021_2_25
  • ID: ymygywzo
    Snippet: Inflammatory and immune processes are defensive mechanisms that aim to remove harmful agents. As a response to infections, inflammation and immune response contribute to the pathophysiological mechanisms of diseases. Coronavirus disease 2019 (COVID-19), whose underlying mechanisms remain not fully elucidated, has posed new challenges for the knowledge of pathophysiology. Chiefly, the inflammatory process and immune response appear to be unique features of COVID-19 that result in developing a hyp
    Document: Inflammatory and immune processes are defensive mechanisms that aim to remove harmful agents. As a response to infections, inflammation and immune response contribute to the pathophysiological mechanisms of diseases. Coronavirus disease 2019 (COVID-19), whose underlying mechanisms remain not fully elucidated, has posed new challenges for the knowledge of pathophysiology. Chiefly, the inflammatory process and immune response appear to be unique features of COVID-19 that result in developing a hyper-inflammatory syndrome, and air pollution, the world’s largest health risk factor, may partly explain the behaviour and fate of COVID-19. Understanding the mechanisms involved in the progression of COVID-19 is of fundamental importance in order to avoid the late stage of the disease, associated with a poor prognosis. Here, the role of the inflammatory and immune mediators in COVID-19 pathophysiology is discussed.

    Search related documents:
    Co phrase search for related documents
    • aberrant activation and acute ards respiratory distress syndrome: 1
    • aberrant activation and acute lung injury: 1, 2, 3, 4
    • aberrant activation and acute phase: 1
    • aberrant activation and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • aberrant activation and acute sars infection: 1
    • aberrant activation and adaptive response: 1, 2, 3, 4
    • aberrant activation and lung damage: 1, 2, 3
    • aberrant activation and lung disease: 1, 2, 3
    • aberrant activation and lung epithelial injury: 1
    • aberrant activation and lung epithelium: 1, 2
    • aberrant activation and lung inflammation: 1
    • aberrant activation and lung injury: 1, 2, 3, 4, 5, 6, 7
    • aberrant activation and lung tissue: 1, 2, 3, 4